Attached files

file filename
EX-32.2 - EX-32.2 - Cardiovascular Systems Inca10-qex322.htm
EX-31.2 - EX-31.2 - Cardiovascular Systems Inca10-qex312.htm
EX-31.1 - EX-31.1 - Cardiovascular Systems Inca10-qex311.htm
EX-10.10 - EX-10.10 - Cardiovascular Systems Inca101amendedandrestated.htm
EX-10.9 - EX-10.9 - Cardiovascular Systems Inca109amendmentno2tosupp.htm
EX-10.8 - EX-10.8 - Cardiovascular Systems Inca108csisvbfirstamendme.htm
EX-10.7 - EX-10.7 - Cardiovascular Systems Inca107formofstockoptiona.htm
EX-10.6 - EX-10.6 - Cardiovascular Systems Inca106formoftime-vestres.htm
EX-10.5 - EX-10.5 - Cardiovascular Systems Inca105formofperformance-.htm
EX-10.4 - EX-10.4 - Cardiovascular Systems Inca104formofboardrsuagre.htm
EX-10.3 - EX-10.3 - Cardiovascular Systems Inca103formofboardrsuagre.htm
EX-10.2 - EX-10.2 - Cardiovascular Systems Inca102formofboardrestric.htm
EX-10.1 - EX-10.1 - Cardiovascular Systems Inca1010amendmentno2topro.htm
10-Q - 10-Q - Cardiovascular Systems Inccsii-20200331.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the filing of the Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 (the “Report”) by Cardiovascular Systems, Inc. (“Registrant”), I, Scott R. Ward, the Chief Executive Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.


Dated: May 7, 2020 
/s/ Scott R. Ward
Scott R. Ward
Chairman, President and Chief Executive Officer